Cancer Epigenetics

• Epigenetic Markers of Early Tumor Development.-Epigenetics of Solid Cancer Stem Cells.-DNA Methylation and Histone Modifications in Breast Cancer.-DNA Methylation Changes in Prostate Cancer.-DNA Methylation in Promoter Region as Biomarkers in Prostate Cancer.-Epigenetics of Bladder Cancer.-Epigenetics in Myeloid Malignancies.-The Epigenetics of Brain Tumors.-DNA Methylation Changes in Cervical Cancers.-Epigenetics of Colon Cancer.-Promoter Methylation in Head and Neck Tumorigenesis.-Epigenome and DNA Methylation in Oral Squamous Cell Carcinoma.-Clinical Implications of Epigenetic Alterations in Human Thoracic Malignancies: Epigenetic Alterations in Lung Cancer.-The Role of microRNAs in the Management of Liver Cancer.- Epigenetics in Ovarian Cancer.-DNA Methylation in Pancreatic Cancer: Protocols for the Isolation of DNA and Bisulfite Modification.-Detection and Analysis of DNA Methylation by Pyrosequencing.-Screening for miRNA Expression Changes using Quantitative PCR (Q-PCR).-Genome-wide Methylation Analysis.-Microarray for Epigenetic Changes: Gene Expression Arrays.-Detecting DNA Methylation using the Methylated CpG Island Amplification and Microarray Technique.- Nutrigenomics – Implications for Breast and Colon Cancer Prevention.-Dietary and Lifestyle Factors of DNA Methylation.-Diet, Epigenetics andCancer.-Role of Epigenetics in Cancer Health Disparities.-Multifactorial Etiology of Gastric Cancer.-Epigenetic Epidemiology for Cancer Risk: Harnessing Germline Epigenetic Variation.-Epigenetic Biomarkers in Cancer Epidemiology.

From the reviews:“This book provides a clear description of the epigenetic changes in cancer that are important in early detection, progression, and prognosis, as well as the design of therapeutic tools necessary to combat cancer. … This is an excellent resource for scientists and oncologists interested in learning about currently available technologies to detect epigenetic changes that serve as biomarkers in detection of early cancerous lesions as well as markers of cancer progression and prognosis.” (Omer Iqbal, Doody’s Book Reviews, August, 2012)